As The World Waits With Bated Breath For The Outcome Of The
On-Going Clinical Trial Of HIV Vaccine In South Africa, Scientists In Nigeria
Appear To Have Hit The Bulleye In The Search For The Effective Medical Cure For
HIV/AIDS.
A research team at the Michael Okpara University of
Agriculture, Umudike (MOUAU), Abia State led by Prof. Maduike Ezeibe has been
able to prove that Medicinal Synthetic Aluminium-magnesium Silicate (MSAMS),
which it developed, can cure HIV/AIDS.The result of the clinical trial of the antiretroviral
efficacy of MSAMS in male and female HIV/AIDS patients was published in the
British Journal of Medicine & Medical Research 18(11):1-7, 2016; Article no
BJMMR.29018.
It was also among the papers presented last Wednesday at the
World Virology Conference 2016 held at Texas, U.S. Though Ezeibe could not
attend the conference because of his inability to raise money for his flight
tickets, the organisers insisted that he sent a video presentation, which was
played and applauded at the conference.Speaking with journalists at the weekend on the apparent
lukewarm attitude of Nigeria’s health authorities to his medical breakthrough,
the professor of Veterinary Medicine said that since 2014 when he was issued
with the national patent right (Ref. No. NG/P/2012/639, 2014) no further step
had been taken to commercialise it or get the international patent right by
Nigeria.“We Africans lack confidence in ourselves,” he lamented,
adding that the medicine that he had discovered to have antiretroviral
properties is an old medicine which had been in use.“The only science we did is that we discovered that it has
charges – negative and positive and since HIV has positive charges, the MSAMS
use its negative charges to attract and destroy HIV,” he said.He said that HIV/AIDS had remained incurable because of the
small size of the virus and immune deficiency it causes hence any
anti-retroviral medicine that could effectively tackle the problem must be
smaller (nano-particles).
According to him, particles of HIV could be as small as
110nm which was why they easily crossed physiological barriers to ‘hide’ in
cells of the brain, bone marrow and testes, which existing antiretroviral
medicines with bigger molecules could not reach.Ezeibe explained: “HIV destroys lymphocytes (immune cells
that clear infections from organs that are inaccessible to medicines. So,
nothing was known that could terminate its infections (and) for that the
infection was said to be in ‘sanctuary’.”The professor reasoned that since Aluminum-magnesium
Silicate (AMS) molecular platelets (nanoparticles) are smaller (0.96nm) than
HIV, the nanoparticles cross physiological barriers to act on all body cells.But the snag was that AMS is not found as mineral deposits
in Nigeria whereas there are large deposits of Aluminum silicate and magnesium
silicate in the country both of which are used as medicines for treatment of
animal and human diseases.So in order to get a purer form of AMS, Ezeibe reacted the
two medicinal minerals (Aluminum silicate and magnesium silicate) and the
Aluminum magnesium silicate was born, the synthetic medicine that has now been
proved to cure HIV/AIDS.“We are using medicine that is so small that wherever HIV
goes it can get there, catch it and destroy it,” he assured.The efficacy of Ezeibe’s synthetic medicine is already
generating interest among medical doctors and those that were involved in the
clinical trial have already joined his research team after using the drug to
treat their patients with astonishing results.
Interestingly, on the day Ezekiel’s research breakthrough
was being presented at the world Virology Conference in Texas, he was also
making a presentation before the Senate of MOUAU. It is now expected that the
university authorities would take up the advocacy to recognise and
commercialise this important breakthrough in medical science by a Nigerian.
No comments:
Post a Comment
Leave Comment Here